The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aclaris Therapeutics, Inc(NASDAQ:ACRS) 
Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational or...
Website: http://www.aclaristx.com
Founded: 2012
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
Aclaris Therapeutics Days Payable Outstanding ttm (DPO)
Aclaris Therapeutics Days Receivable Outstanding ttm (DSO)
Aclaris Therapeutics Days Inventory Outstanding ttm (DIO)
Aclaris Therapeutics Op Cashflow Per Share ttm
Aclaris Therapeutics Free Cashflow Per Share ttm
Aclaris Therapeutics Cash Per Share ttm
Aclaris Therapeutics P/S ratio ttm
Aclaris Therapeutics (GAAP) P/E ratio ttm
Aclaris Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.